维普中文期刊产品整合服务
181篇 您的检索式:作者名="Niho"
    题名 作者 年代 出处 被引量
1Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinoma显示文摘Tatsuya Yoshida Genichiro Ishii Koichi Goto Kiyotaka Yoh Seiji Niho Shigeki Umemura Shingo Matsumoto Hironobu Ohmatsu Kanji Nagai Yuichiro Ohe Atsushi Ochiai 2013Journal of Cancer Research and Clinical Oncology2013,,10:3
2Dose-escalation study of thoracic radiotherapy in combination with pemetrexed plus cisplatin followed by pemetrexed consolidation therapy in japanese patients with locally advanced nonsquamous nonsmall-cell lung cancer显示文摘Niho S Kubota K Nihei K 2013Clinical Lung Cancer2013,14,1:1
3Randomized phase I] study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non- squamous non-small-cell lung cancer 显示文摘Niho S Kunitoh H Nokihara H 2012Lung Cancer2012,76,3:1
4High body mass index correlates with increased risk of venous irritation by vinorelbine infusion显示文摘Yoh K Niho S Goto K 2004Jpn J Clin Oncol2004,34,:1
5Low-dose irinotecan as a second-line chemotherapy for recurrent small cell lung cancer 显示文摘Morise M Niho S Umemura S 2014Jpn J Clin Oncol2014,44,9:1
6Tumor markers in lung cancer 显示文摘 SHINKAI T 2001Gan To Kagaku Ryoho2001,28,13:1
7First - line single agent treatment with gefitinib in patients with advanced non -small -cell lung cancer: A phase II study 显示文摘Niho S Kubota K Coto K 2006J Clin Oncol2006,24,1:1
8High body mass index correlates with increased risk of venous irritation by vinorelbine infusion显示文摘Yoh K Niho S Goto K 2004Jpn J Clin Oncol2004,34,4:1
9Clinical features of unreseetable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens显示文摘Shimada Y Niho S Ishii G 2012Lung Cancer2012,75,3:1
10Phase II study of topote?can with cisplatin inJapanese patients with small cell lung cancer显示文摘Hosomi Y Shibuya M Niho S et a1 2011Anticancer Res2011,31,10:1
11Monoclonality of both pale cells and cuboidal cells of sclerosing hemangioma of the lung显示文摘 Suzuki K Yokose T 1998Am J Pathol1998,152,4:1
12Phase study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancer显示文摘Niho Y Kakinumar 2002Lung Cancer2002,35,:1
13显示文摘Niho S Nishiwaki Y Goto K 2000Lung Cancer2000,27,3:1
14Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity显示文摘Yoh K Niho S Goto K 2007Lung Cancer2007,55,:1
15A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma(large cell neuroendocrine carcinoma and small cell lung cancer)显示文摘Kenmotsu H Niho S Ito T 2014Lung Cancer2014,45,2:1
16Subchronic toxicity study of gallic acid by oral administration in F344 rats显示文摘Niho N Shibutani M Tamura T 2001Food Chem Toxicol2001,39,:1
17Significance of serum prcgas- trin-releasing peptide as a predictor of relapse of small cell lung canc er: comparative evaluation with neuron-specific enolase and carcino- embryonic antigen 显示文摘Niho S Nishiwaki Y Goto K 2000Lung Cancer2000,27,3:1
18Phase Ⅱ study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced nonsmall cell lung cancer显示文摘Niho Y Kokinuma R 2002Lung Cancer2002,35,:1
19Randomized muhicenter phase II1 tria of irinotecan ( CPT-11 ) and cisplatin (CDDP) versus CDDP and vindesine (VDS) in patients with advanced non-small cell lung cancer (NSCLC) 显示文摘Niho S Nagao K Nishiwaki Y 1999Proc Am Soc Clin Oncol1999,18,:1
20High body mass index corre- lates with increased risk of venous irritation by vinorelbine infusion 显示文摘Kiyotaka Yoh Seiji Niho Koichi Goto 2004Jpn J Clin 0ncol2004,34,4:1
返回顶部 每页显示:
共10页 首页 上一页 第1页 下一页 末页 /10 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费